Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital

This study applied a structural equation modeling (SEM) to evaluate the role of substance use (alcohol, smoking, and trado-medicine use) to changes in the liver enzymes (AST, ALT, and ALP) levels in HIV-infected adult patients on a highly active antiretroviral treatment (HAART) for not <1 yea...

Full description

Bibliographic Details
Main Authors: Chinwe F. Anyanwu, Tamuno-Olobo JohnBull, Ibe M. Usman, Eric O. Aigbogun, Joy Ochai, Ahmed H. Qasem, Shadi S. Alkhayyat, Athanasios Alexiou, Gaber El-Saber Batiha
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Reproductive Health
Subjects:
SEM
Online Access:https://www.frontiersin.org/articles/10.3389/frph.2021.664080/full
id doaj-893e53d1865b443284b5cc5da9f3f4c4
record_format Article
spelling doaj-893e53d1865b443284b5cc5da9f3f4c42021-06-28T06:57:29ZengFrontiers Media S.A.Frontiers in Reproductive Health2673-31532021-06-01310.3389/frph.2021.664080664080Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching HospitalChinwe F. Anyanwu0Tamuno-Olobo JohnBull1Ibe M. Usman2Eric O. Aigbogun3Joy Ochai4Ahmed H. Qasem5Shadi S. Alkhayyat6Athanasios Alexiou7Athanasios Alexiou8Gaber El-Saber Batiha9Department of Pharmacology, Faculty of Basic Clinical Sciences, University of Port Harcourt, Port Harcourt, NigeriaDepartment of Human Anatomy, Faculty of Basic Medical Sciences, Niger Delta University, Amassoma, NigeriaDepartment of Anatomy, Faculty of Biomedical Sciences, Kampala International University, Kampala, UgandaDepartment of Public Health Science, Faculty of Science and Technology, Cavendish University, Kampala, UgandaHuman Anatomy Department, Faculty of Basic Medical Sciences, Ahmadu Bello University, Zaria, NigeriaLaboratory Medicine Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Mecca, Saudi ArabiaDepartment of Internal Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi ArabiaNovel Global Community Educational Foundation, Hebersham, NSW, AustraliaAFNP Med Austria, Wien, Austria0Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour, EgyptThis study applied a structural equation modeling (SEM) to evaluate the role of substance use (alcohol, smoking, and trado-medicine use) to changes in the liver enzymes (AST, ALT, and ALP) levels in HIV-infected adult patients on a highly active antiretroviral treatment (HAART) for not <1 year. The study was a cross-sectional, part of a randomized comparative trial (Ref: UPH/CEREMAD/REC/19), involving 129 (46 males and 83 females) HIV-infected adult patients. Liver enzyme levels were determined from analyzed blood samples using the Clinical Chemistry Analyser (VS10) manufactured by Vitro Scient, while the study determined substance use using a reliable (Cronbach alpha = 0.805) rapid-exploratory survey questionnaire. Liver enzyme values were further categorized into: normal or abnormal using normal reference ranges (ALT = 7–55 U/L, AST = 8–48 U/L, and ALP = 40–129 U/L). STATGRAPHICS V16.1.11 (StatPoint Tech., Inc.) and SPSS (IBM® Amos V21.0.0, USA) were used to analyze the data. Among the HIV-HAART patients, 27.9% were alcohol users, 20.9% smokers, and 20.1% trado-medicine users. In addition, ALP (71.3%) abnormality was higher than ALT (34.9%) and AST (28.7%). The result from the SEM provided only a partial support for our hypotheses of direct substance use effects on the liver enzyme levels and abnormalities; with a direct association of alcohol with an elevated AST (b = 0.170, p = 0.05) and smoking with a higher AST (b = 0.484, p < 0.01) and ALT (b = 0.423, p < 0.01) values. Trado-medicine use was not directly associated with enzyme elevation and abnormality. In conclusion, ALP abnormality was the most common, and there is a close association between an elevated ALT and AST, with or without an elevated ALP. The study found that HIV-HAART patients who drink or smoke will have at least one or more abnormal transaminases. The possible explanation to the increased risk among HIV-HAART patients could be associated with the metabolic pressures and supra-additive effects on the livers.https://www.frontiersin.org/articles/10.3389/frph.2021.664080/fullSEMsubstance useenzyme levelsHAARTHIV-infected adults
collection DOAJ
language English
format Article
sources DOAJ
author Chinwe F. Anyanwu
Tamuno-Olobo JohnBull
Ibe M. Usman
Eric O. Aigbogun
Joy Ochai
Ahmed H. Qasem
Shadi S. Alkhayyat
Athanasios Alexiou
Athanasios Alexiou
Gaber El-Saber Batiha
spellingShingle Chinwe F. Anyanwu
Tamuno-Olobo JohnBull
Ibe M. Usman
Eric O. Aigbogun
Joy Ochai
Ahmed H. Qasem
Shadi S. Alkhayyat
Athanasios Alexiou
Athanasios Alexiou
Gaber El-Saber Batiha
Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital
Frontiers in Reproductive Health
SEM
substance use
enzyme levels
HAART
HIV-infected adults
author_facet Chinwe F. Anyanwu
Tamuno-Olobo JohnBull
Ibe M. Usman
Eric O. Aigbogun
Joy Ochai
Ahmed H. Qasem
Shadi S. Alkhayyat
Athanasios Alexiou
Athanasios Alexiou
Gaber El-Saber Batiha
author_sort Chinwe F. Anyanwu
title Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital
title_short Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital
title_full Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital
title_fullStr Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital
title_full_unstemmed Substance Use, Highly Active Antiretroviral Therapy, and Liver Enzymes: Evidence From a Cross-Sectional Study of HIV-Infected Adult Patients Without Comorbidities on HAART in the University of Port Harcourt Teaching Hospital
title_sort substance use, highly active antiretroviral therapy, and liver enzymes: evidence from a cross-sectional study of hiv-infected adult patients without comorbidities on haart in the university of port harcourt teaching hospital
publisher Frontiers Media S.A.
series Frontiers in Reproductive Health
issn 2673-3153
publishDate 2021-06-01
description This study applied a structural equation modeling (SEM) to evaluate the role of substance use (alcohol, smoking, and trado-medicine use) to changes in the liver enzymes (AST, ALT, and ALP) levels in HIV-infected adult patients on a highly active antiretroviral treatment (HAART) for not <1 year. The study was a cross-sectional, part of a randomized comparative trial (Ref: UPH/CEREMAD/REC/19), involving 129 (46 males and 83 females) HIV-infected adult patients. Liver enzyme levels were determined from analyzed blood samples using the Clinical Chemistry Analyser (VS10) manufactured by Vitro Scient, while the study determined substance use using a reliable (Cronbach alpha = 0.805) rapid-exploratory survey questionnaire. Liver enzyme values were further categorized into: normal or abnormal using normal reference ranges (ALT = 7–55 U/L, AST = 8–48 U/L, and ALP = 40–129 U/L). STATGRAPHICS V16.1.11 (StatPoint Tech., Inc.) and SPSS (IBM® Amos V21.0.0, USA) were used to analyze the data. Among the HIV-HAART patients, 27.9% were alcohol users, 20.9% smokers, and 20.1% trado-medicine users. In addition, ALP (71.3%) abnormality was higher than ALT (34.9%) and AST (28.7%). The result from the SEM provided only a partial support for our hypotheses of direct substance use effects on the liver enzyme levels and abnormalities; with a direct association of alcohol with an elevated AST (b = 0.170, p = 0.05) and smoking with a higher AST (b = 0.484, p < 0.01) and ALT (b = 0.423, p < 0.01) values. Trado-medicine use was not directly associated with enzyme elevation and abnormality. In conclusion, ALP abnormality was the most common, and there is a close association between an elevated ALT and AST, with or without an elevated ALP. The study found that HIV-HAART patients who drink or smoke will have at least one or more abnormal transaminases. The possible explanation to the increased risk among HIV-HAART patients could be associated with the metabolic pressures and supra-additive effects on the livers.
topic SEM
substance use
enzyme levels
HAART
HIV-infected adults
url https://www.frontiersin.org/articles/10.3389/frph.2021.664080/full
work_keys_str_mv AT chinwefanyanwu substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT tamunoolobojohnbull substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT ibemusman substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT ericoaigbogun substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT joyochai substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT ahmedhqasem substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT shadisalkhayyat substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT athanasiosalexiou substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT athanasiosalexiou substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
AT gaberelsaberbatiha substanceusehighlyactiveantiretroviraltherapyandliverenzymesevidencefromacrosssectionalstudyofhivinfectedadultpatientswithoutcomorbiditiesonhaartintheuniversityofportharcourtteachinghospital
_version_ 1721356875385012224